Loading provider…
Loading provider…
Gastroenterology Physician in Chula Vista, CA
NPI: 1447464912Primary Practice Location
SHARP CHULA VISTA MEDICAL CENTER
751 Medical Center Ct, Chula Vista, CA
Primary Employer
Ivan Cubas MD Inc
prospectmedical.com
HQ Phone
Get MD Ivan's Phone Numberphone_androidMobile
Get MD Ivan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardND State Medical License
CA State Medical License
CA State Medical License
2013 - 2026
ND State Medical License
2024 - 2026
CO State Medical License
2023 - 2025
MI State Medical License
2002 - 2016

American Board of Internal Medicine
Gastroenterology
Beth Israel Deaconesss Medical Center
2008 - 2009
2008 - 2009
Ascension Providence/MSUCHM
Fellowship • Gastroenterology
2006 - 2009
Beth Israel Deaconess Medical Center
Fellowship • Transplant Hepatology
2005 - 2006
Henry Ford Health/Henry Ford Hospital
Residency • Internal Medicine
2002 - 2005
Cayetano Heredia University
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99204New patient office or other outpatient visit, 45-59 minutes | 70 | 70 |
| 2 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 68 | 77 |
| 3 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 47 | 47 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 26 | 30 |
| 5 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 25 | 27 |
Use of double-balloon enteroscopy to diagnose a primary intestinal melanoma
Authors: Ivan Cubas, Serge Sorser, Laurence Stawick
Lead Sponsor: Hanmi Pharmaceutical Company Limited
Intervention / Treatment: DRUG: Placebo of HM15211, DRUG: HM15211
Lead Sponsor: Allegiance Health
Intervention / Treatment: DRUG: Domperidone
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab, DRUG: Ustekinumab